Rhonda Lee Jessum, PHD | |
280 N. Westlake Blvd. Suite 205, Westlake Blvd., CA 91362-7020 | |
(818) 880-0250 | |
Not Available |
Full Name | Rhonda Lee Jessum |
---|---|
Gender | Female |
Speciality | Clinical Psychologist |
Experience | 29 Years |
Location | 280 N. Westlake Blvd. Suite 205, Westlake Blvd., California |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1457400400 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
103TC0700X | Psychologist - Clinical | PSY15775 (California) | Primary |
Mailing Address | Practice Location Address |
---|---|
Rhonda Lee Jessum, PHD 4831 Las Virgenes Rd # 177, Calabasas, CA 91302-1911 Ph: (818) 880-0250 | Rhonda Lee Jessum, PHD 280 N. Westlake Blvd. Suite 205, Westlake Blvd., CA 91362-7020 Ph: (818) 880-0250 |
News Archive
Patients with an aggressive lymphoma that often relapses and kills within two years experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commercially-available drug that made chemotherapy more effective.
Canadian researchers have found more evidence that older adults aren't able to filter out distracting information as well as younger adults.
Flextronics today announced that it will expand its existing partnership with Citrix Systems, Inc. to include the joint design of Citrix's next generation hardware for WAN optimization and secure access appliances and primary outsourcing partner. Flextronics has provided manufacturing and logistics solutions to Citrix for more than five years.
Angiochem, Inc., a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier (BBB) through LRP-1 targeting, announced today that complete phase 1/2 clinical data in two clinical studies of its lead oncology program, ANG1005, for the treatment of brain cancers, including glioblastoma (GBM) and brain metastases, were presented at the 2010 American Society for Clinical Oncology (ASCO) Annual Meeting, June 4-8, in Chicago, IL.
› Verified 9 days ago